TriSalus Life Sciences, Inc.: First Light Asset Management, LLC amends Schedule 13G stake filing
Not investment advice. Muhabbit scores how much a story may matter, not which way to trade.
First Light Asset Management amended its Schedule 13G filing on TriSalus Life Sciences, disclosing a change in its passive stake in the company. The filing, submitted under SEC accession number 0001999371-26-025526, updates the investment firm's previously reported position in the medical device maker. Schedule 13G amendments are typically filed when an investor's ownership percentage crosses certain thresholds or when there are material changes to a previously reported position. The specific size and direction of the stake change were not detailed in the filing headline. Investors will watch for further disclosures to gauge First Light's current ownership level and whether the shift signals a change in its conviction on TriSalus.
Muhabbit's AI wrote this summary in its own words from SEC EDGAR SCHEDULE 13G's report. It can get details wrong, so check the source.
Named in this story
TriSalus Life Sciences, Inc., First Light Asset Management, LLC